Navigation Links
Activity Against MRSA is the Most Important Attribute Influencing Physicians' Antibiotic Selection for the Treatment of Skin and Skin Structure Infections
Date:11/4/2008

Success of Zyvox and Cubicin is Driven Strongly by Agents' Excellent Activity Against MRSA, According to a New Report from AMR and Decision Resources

MALVERN, Pa. and WALTHAM, Mass., Nov. 4 /PRNewswire/ --Arlington Medical Resources (AMR) and Decision Resources find that with the rising incidence of skin infections caused by methicillin-resistant Staphylococcus aureus (MRSA), an overwhelming majority of surveyed physicians indicate that the most important attribute influencing antibiotic selection in skin and skin structure infections (SSSIs) is activity against MRSA. Other factors that influence drug selection include an agent's skin penetration and its ability to avoid the development of resistant pathogens.

"Physicians we surveyed also indicate that the two most important factors that influence hospital prescribing for SSSIs are recommendations from infectious disease consults and the Infectious Diseases Society of America (IDSA) guidelines. Clinicians treating patients with SSSIs look to these specialists and guidelines for direction when managing SSSI patients," stated John Lebbos, M.D., vice president of infectious diseases at Decision Resources.

The new report entitled Hospital Anti-Infectives Insight Series: Skin & Skin Structure Infections also finds that surveyed physicians state that the success of Pfizer's Zyvox and Cubist Pharmaceuticals' Cubicin is driven strongly by these agents' excellent activity against MRSA. Vancomycin remains the most commonly prescribed agent for empiric coverage of MRSA, and its use is largely driven by familiarity and local hospital guidelines. In contrast, surveyed physicians indicate that use of Zyvox and Cubicin is driven by product attributes, namely their excellent activity against MRSA activity.

About Hospital Anti-Infectives Insight Series

AMR and Decision Resources' new Hospital Anti-Infectives Insight Series analyzes hospital antibiotic prescribing patterns using AMR's compreh
'/>"/>

SOURCE Arlington Medical Resources; Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Tufts Nelson a leader on Physical Activity Guidelines advisory committee
2. Vigorous activity protects against breast cancer
3. YMCA of the USA Supports New National Physical Activity Guidelines
4. ACSM, AHA Support Federal Physical Activity Guidelines
5. Walking forum report shows need to expand physical activity in schools
6. New way to control protein activity could lead to cancer therapies
7. Social Network For Affordable Health Care Supporters Stimulates A New Level of Interactivity and Dialogue
8. Social Network for Affordable Health Care Supporters Stimulates a New Level of Interactivity and Dialogue
9. Banque Centrale Populaire Consolidates Activity Abroad With New Trade Finance Solutions From Misys
10. Gene Activity May Explain Deadlier Breast Cancers Among Younger Women
11. Seizures in newborns can be detected with small, portable brain activity monitors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... HAPPYneuron,s most popular an...the iPhone and iPod Touch. , ... HAPPYneuron,s most popular and addictive game, Sp...Touch. Split Words is designed to help banish that...litWords iPhone brain game challenges the brain ...
(Date:11/20/2009)... , Pioneering Neurologist Closer to Understandi.... 20 Dr. Jeremy Schmahm...ool and neurologist at the Massachusetts General H...nted his laboratory,s research on the new field of...MINDlink Foundation. ,, Dr. Schmahmann is an aw...
(Date:11/20/2009)... , QUINCY, Mass., Nov. 20 Follo...rmarket Company removed from sale Shedd,s Country ...ice and Shedd,s Country Crock ® Side Dishes D...te allergen. ,, The following code dates and U...74; Side Dishes DELUXE Cheddar Broccoli Rice 21 oz...
(Date:11/20/2009)... , ST. LOUIS, Nov. 20 /PRNewswire-FirstCall/...ounced that it will present at the Bank of America...December 2-3, 2009, at the Crowne Plaza Hotel Time...ent Wednesday, December 2nd at 8:30 a.m. Eastern T...cess a live, audio webcast of Centene,s presentati...
(Date:11/20/2009)... , NEW YORK, Nov. 20 /PRNewswire-FirstCall...unced that it will broadcast Doctor Radio Repor...s , an in-depth special hosted by veteran journali...com/cgi-bin/prnh/20080819/NYTU044LOGO ) ,, Doc...w About Mammograms will air November 21 live at...
Breaking Medicine News(10 mins):Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5
...for the development of muscles.Da-Zhi Wang and oth... at Chapel Hill // said that the genes are among a... worm 12 years ago. Only in the past few years...appeared in the latest online edition of the journ...
...ni pharmaceutical companies are keen to enhance bu...nment // to relax the stringent visa norms. Pa...and raw materials provided by the Chinese, apart f...sman for the Pakistan Pharmaceutical Manufacturers...
... Research Center has reported that maintaining the...reduce the risk // of cardiovascular disease. The...he blood glucose level of their patients less than...the last few months, the test measures the amount ...
...ed in his recent article that having induced abort...Dr. Brind has compiled data from recent studies of...rnal of American Physicians and Surgeons. Pr...ncrease the risk of developing breast cancer and e...
... increased risk of developing eye problems. A revi...and Zohar Habot-Wilner // , Goldschleger Eye Insti... reviews and found that risk of developing eye pro... found that obese people have high risk of develop...
...l can do to people. High-fat diets cause many pati...g at food labels // to know what they consume. ...r for consumers to avoid trans fats, which plug ar...o vegetable oils to improve shelf life. If a produ...
Other Medicine News:Health News:Pakistan drug companies seek trade ties with India 2Health News:Food labels to include information on trans fats in US 2Health News:Food labels to include information on trans fats in US 3
(Date:11/20/2009)...ire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ...ief Executive Officer, and Greg Browne, Chief Fina...er Jaffray Health Care Conference in New York on W...onference session and webcast will be audio only a...ray will host a webcast of the presentation live a...
(Date:11/20/2009)...0 BD (Becton, Dickinson ...mpletion of its acquisition of HandyLab, Inc., an ...d manufactures molecular diagnostic assays and aut...Lab announced an exclusive agreement for BD to dev...dyLab Jaguar(TM) platform, the first fully integra...
(Date:11/20/2009)...PRNewswire-FirstCall/ -- Soligenix, Inc. (OTC Bull...erly known as DOR BioPharma, Inc., a late-stage bi...ormed a consortium to develop thermostable technol...vaccines. Soligenix received a $9.4 million grant ...ous Diseases (NIAID), a division of the National I...
Breaking Medicine Technology:Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 1Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 2Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 3Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 4Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 1Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 2Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 3Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 4Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 5Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 6Torn Surgical Gloves Put Patients at Risk for Infection 49069 1Torn Surgical Gloves Put Patients at Risk for Infection 49069 2
...t fails to mention ongoing FDA-approved HIFU clini...nical data on HIFU outcomes and experience, CHARL...stributor of the minimally invasive Sonablate(R) 5...h America, announced that the June 16, 2008,editio... intensity focused,ultrasound (HIFU) for treating ...
...ubmission Based on Data from Placebo-Controlled Ph...tients in a Randomized Study, WOODCLIFF LAKE, N.J...ounced today that the U.S. Food and Drug Administr...plemental biologics license,application (sBLA) for...d,approval indication into full approval. It is ba...
Other Medicine Technology:ABC News NIGHTLINE Features HIFU with Sonablate(R) 500 as Non Invasive Treatment Option for Prostate Cancer 2ABC News NIGHTLINE Features HIFU with Sonablate(R) 500 as Non Invasive Treatment Option for Prostate Cancer 3FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL) 2FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL) 3FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL) 4FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL) 5
...Drug Screen Tests are available in 14 configuratio...Designed using Microgenics Antibody Technology, th...point of care immunoassay targeted to detect MDMA ...cross-reactivity to any isomer of methamphetamine ...
...ite test! QuickScreen™ multi-panel dip cards...our choice of any conceivable combination of 9 dif...r total flexibility for your drug testing program....-in timer tells you when to read the results. Our ...
Insure
...tely 500,000 people die each year of colon cancer ...mprovements (high contrast berium enema, colonosco...e in the success rate of curative treatment for co... past two decades. The chances of successful treat...
Medicine Products: